Cachexia: a therapeutic approach beyond cytokine antagonism.
about
The translational aspect of complementary and alternative medicine for cancer with particular emphasis on KampoUncoupling of inflammation and insulin resistance by NF-kappaB in transgenic mice through elevated energy expenditureOptimal management of cancer anorexia-cachexia syndrome.Nutrition modulation of cachexia/proteolysis.Muscle wasting and cachexia in heart failure: mechanisms and therapies.Development aggravates the severity of skeletal muscle catabolism induced by endotoxemia in neonatal pigsCardiac cachexia.Future prospects of anticytokine therapy in chronic heart failure.Progranulin regulates zebrafish muscle growth and regeneration through maintaining the pool of myogenic progenitor cellsEmerging drugs for cancer cachexia.Rheumatoid cachexia: a clinical perspective.Amino acids, independent of insulin, attenuate skeletal muscle autophagy in neonatal pigs during endotoxemia.Regulation of energy metabolism by inflammation: a feedback response in obesity and calorie restriction.Proteolysis in illness-associated skeletal muscle atrophy: from pathways to networks.The role of inflammatory pathways in cancer-associated cachexia and radiation resistance.Mechanisms for cachexia in heart failure.Sarcopenia in solid organ transplantation.The wasting continuum in heart failure: from sarcopenia to cachexia.Rosiglitazone and imidapril alone or in combination alleviate muscle and adipose depletion in a murine cancer cachexia model.
P2860
Q26795520-6CF7109A-CC22-4BD4-BBB0-3C0E333D300EQ33717545-D7443570-5ADB-42FB-B36C-A5D97CDA675BQ34417908-CFB5C487-5711-479F-B9A2-C6C5BCC71226Q34565917-B82812ED-6E84-4815-894F-086129148D93Q34681621-71878776-6549-4947-8766-F8DBFADF10BEQ35842227-24A80A59-6D01-44FD-B010-8D49C2DCC2CAQ35932382-420D3DE6-3B6C-43B4-A41A-0925BEABCCC0Q36087238-45D5E223-8C36-4EAB-960E-37F8A877B18CQ36576221-AE89A05C-EF45-4DA6-989A-EB1AB3EC7431Q36989913-F1F24593-62D6-4C5F-9435-F2B284A55B40Q37151582-6737B839-5F67-4885-AE11-103491835F3FQ37201322-29EEC5B9-B52C-41CE-BAA8-9FA302A59667Q37770377-E8AC5EEA-86DC-42DE-90C5-CFAAA846E23FQ37893657-33B2CEB9-E7A6-471A-ACF7-4C6F725A2A4DQ38115997-85954D93-573A-40F6-8B97-D5DF421B4600Q38127358-D002FBB0-CCB1-4529-ADE9-F8F6231319D2Q38188425-210A930D-31A2-4F2D-8A15-A461F17CDE41Q38564746-4482E726-B856-44AD-A1A3-AC0ACE41E958Q47743670-70E3D771-8EEE-45FE-8C70-66E981D9F457
P2860
Cachexia: a therapeutic approach beyond cytokine antagonism.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cachexia: a therapeutic approach beyond cytokine antagonism.
@ast
Cachexia: a therapeutic approach beyond cytokine antagonism.
@en
type
label
Cachexia: a therapeutic approach beyond cytokine antagonism.
@ast
Cachexia: a therapeutic approach beyond cytokine antagonism.
@en
prefLabel
Cachexia: a therapeutic approach beyond cytokine antagonism.
@ast
Cachexia: a therapeutic approach beyond cytokine antagonism.
@en
P2093
P1476
Cachexia: a therapeutic approach beyond cytokine antagonism.
@en
P2093
Genth-Zotz S
von Haehling S
P304
P356
10.1016/S0167-5273(02)00245-0
P577
2002-09-01T00:00:00Z